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Tubal patency is a key element in women who are undergoing assisted reproductive techniques (ART), in order to attempt or
exclude intrauterine insemination (IUI) cycles. Amongst the different procedures that can be used, without resorting to laparoscopy
that remains the gold standard, hystero-salpingo-contrast sonography (HyCoSy) is an acceptable, time-efficient, and well tolerated
option; it can be performed with administration of saline and air simultaneously or alternately (air/saline-HyCoSy), or with some
other contrast agents, like SonoVue (sulfur hexafluoride microbubbles). In this paper, we describe two different studies: in the first
one, our aim is to compare the efficiency of air/saline-HyCoSywithHyCoSy performedwith contrastmedia (SonoVue), considering
hysterosalpingography (HSG) and laparoscopy (LPS) as reference tests; in the second one, we estimate the pregnancy rate of a cohort
of infertile women selected to undergo IUI cycles after tubal bilateral patency demonstrationwith air/saline-HyCoSy, to understand
if this technique can be used as an efficient screening procedure in a Reproductive Unit.
1. Introduction
Assessment of tubal patency is a first-step examination in
the evaluation of the infertile women. Laparoscopy with
chromopertubation is considered the gold standard test
for tubal assessment, adding hysteroscopy to the proce-
dure for concomitant evaluation of the intrauterine cavity.
Laparoscopy thus can lead to a final assessment of pelvic
factors; however, even this direct visualization technique
never reaches a perfect correlation with fertility outcome
and it exposes patients to potential surgical complications
[1, 2]. Besides, noninvasive techniques can be used to assess
tubal patency. Hysterosalpingography (HSG) is still the first-
line diagnostic examination in some fertility centers, but
it also shows limits and potential risks: on one side, it
enables poor or no evaluation of the uterus and the ovaries;
on the other side, it exposes to ionizing radiation and
potentially allergenic contrast media. The introduction of
hystero-salpingo-contrast sonography (HyCoSy) provides an
increasingly common alternative, proven to be an accept-
able, time-efficient, and well tolerated option to HSG with
comparable accuracy in the assessment of the uterine cavity
and tubal patency [3, 4]. HyCoSy can be performed with
administration of saline and air simultaneously or alternately
(air/saline-HyCoSy), or with some other contrast agents [5].
Some investigators [6, 7] have demonstrated the limitations of
conventional two-dimensionalHyCoSy (2D-HyCoSy), which
are mainly due to the fact that the fallopian tubes are rarely
visualized completely because of their anatomical tortuosity.
Furthermore, spill of the positive medium from the distal
ostium could be difficult to distinguish from the surrounding
bowels. To overcome these limits, three-dimensional imaging
with HyCoSy has been proposed [8]. We performed two
studies. In the first one the main purpose was to evaluate the
efficacy of contrast-tuned imaging technology (CnTI-Sono
Vue-HyCoSy) compared to air/saline-HyCoSy, considering
both laparoscopy and hysterosalpingography as diagnostic
reference standards. In the second one the aim was to
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Figure 1: Assessment of tubal patency with air/saline hysterosalpingography. (a) shows the image of anexa with US contrast. (b) Red arrows
show the hyperechoic echo of air/saline contrast media.
compare the pregnancy rate in infertile women undergoing
air/saline-HyCoSy and intrauterine insemination to the preg-
nancy rate in fertile population.
2. Materials and Methods
We performed two different studies in order to evaluate the
tubal patency in women with infertility problems.
2.1. Study One. Forty-two patients undergoing investiga-
tion for subfertility underwent HyCoSy during the prolif-
erative phase of the menstrual cycle. Transvaginal ultra-
sound was performed using a Technos MPX (ESAOTE SpA,
Genova, Italy) ultrasound machine and a high-resolution
(5.0–9.0MHz) endovaginal probe. A basic scanning was
performed to evaluate any abnormal findings of the uterus
and ovaries. Informed consent was obtained from all patients
according to local Institutional Review Board procedures.
After accurate cleaning of the cervix and vagina with an
iodinated solution, an 8-Fr catheter (pediatricNelathon; Tele-
flex Medical S.r.l., Varedo, Italy) was introduced transcervi-
cally. After successful catheter placement, the two diagnostic
procedures were performed sequentially. We started with a
HyCoSy using saline with air as contrast medium (air/saline-
HyCoSy) and ultrasound performed on the 2D setting and B-
mode. Five to tenmillilitres of sterile saline were first injected
into the uterine cavity to determine whether there were any
intracavitary abnormalities; subsequently, 30mL of air was
gently injected to induce the bubbling effect and visualize
the positive signal in the tubal lumen (Figure 1). With
the same catheter, we performed the second HyCoSy using
SonoVue as contrast media (sulfur hexafluoride microbub-
bles; Bracco Imaging S.p.a., Milan, Italy) and scanning using
the CnTI-SonoVue-HyCoSy. The CnTI-technology works at
very low acoustic pressure (Mechanical index < 0.1). At
such a low acoustic pressure, tissues do not exhibit any
harmonic response, while microbubbles give a signal that is
picked up by the transducer [9]. Second-generation contrast
media use very stable microbubbles, with minimal bubble
destruction [10]. We diluted 4.8mL of SonoVue with 20mL
of saline and used 5–10mL of the final solution for each
patient.
No antispasmodic drugs were used. If the patients had
a recent (30 days) negative cervical swab for chlamydia and
mycoplasma and negative vaginal swab, no antibiotics were
administered. Otherwise, we opted for antibiotic prophylaxis
with doxycycline (doxycycline, 200mg) one-half hour before
the procedure or azithromycin (Azithromycin, 500mg) start-
ing 2 days before the procedure and finishing on the day of the
procedure.
In this series of patients, the final diagnosis was obtained
within 2 months from the HyCoSy, either by conventional
HSG or by LPS in selected cases. The diagnosis of tubal
patency for saline andB-mode ultrasoundwas obtainedwhen
the following criteria weremet: (1) visualization of the flow of
contrast media in the tubes without dilatation of the lumen;
(2) appearance of contrast media in the peritoneal cavity near
the ovaries (hyperechoic image).
The diagnosis of tubal patency for CnTI-SonoVue-Hy-
CoSy was obtained with the direct display of the contrast
medium first in the uterine cavity and immediately thereafter
in the tubes. Evocation of pain during the distension of the
uterine cavity without visualization of flow in the tubes was
an additional criterion of organ damage.
2.2. Study Two. Two hundred infertile patients were analysed
with air/saline-HyCoSywith the sameprocedure described in
study one. Data were recorded and analysed. In the presence
of a bilateral patency, patients were sent to the Reproductive
Unit for intrauterine insemination. In the presence of at least
one occluded tube, patients were admitted to an IVF cycle.
Couples admitted to IUI underwent ovulation induction
using gonadotropins. A low dose (75 IU) (Gonal F, Ares-
Serono, UK or Puregon, Organon, France) of recombinant
FSH was given from day 3 to the day of ovulation induction
(HCG 5000 IU) based on follicle ultrasound monitoring
from day 8 to a dominant follicle of 18mm mean diameter.
Insemination was performed 36 h after HCG administration.
For the IUI, we use only fresh sperm; inclusion criteria for this
study were as follows: no relevant systematic disease, body
mass index ≤ 30 kg/m2, normal karyotype, and normal follic-
ular stimulating hormone (FSH), luteinizing hormone (LH),
prolactin (PRL), and thyroid-stimulating hormone (TSH). In
couples admitted to IVF, FSH injections for multifollicular
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Table 1: Air/saline-HyCoSy versus HSG/LPS (81 tubes, 42 patients).
Air/saline-HyCoSy HSG/LPS
Patent Occluded Total
Patent 41 2 43
Occluded 17 21 38
Total 58 23 81
ovarian stimulationwere started at a dose of 150–300 IU every
day. Final oocyte maturation was induced using 10,000 IU of
human chorionic gonadotropin when at least three 18mm
follicles were seen on ultrasound scan. Ultrasound guided
oocyte retrieval was done 34–38 h after human chorionic
gonadotropin administration. Progesterone supplementation
was used for luteal phase support and continued for up to
8 weeks of gestation if pregnancy had occurred. Embryo
transfer was performed under transabdominal ultrasound
guidance 2, 3, or 5 days after oocyte retrieval depending on
the number and quality of the embryos available and the
patient’s will.
2.3. Statistical Analysis. We considered the presence of an
occluded tube as testing positive and the presence of a
patent tube as negative. Inconclusive examinations were
recorded. To assess the diagnostic accuracy, these exam-
inations were grouped together with the occluded group.
Parametric descriptive statistics were used for demographic
data. The diagnostic accuracy of the two techniques was
calculated, and Cohen’s kappa value was used to compare the
results of different examinations. The diagnostic accuracy of
air/saline-HyCoSy and CnTI-SonoVue- HyCoSy obtained in
the second half of this series was compared with the results
obtained in the first half to evaluate the possible impact of a
learning phase.
3. Results
3.1. Study One. The mean age of patients enrolled for this
study was 35 years, with an SD of 4.5 years. Of the 42
patients enrolled, 26 patients underwent HSG and 16 patients
underwent LPS to assess tubal patency and to guide clinical
management.
In Table 1, we report the results of the air/saline-HyCoSy
compared with these examinations. Air/saline-HyCoSy had
a sensitivity, specificity, and positive and negative predic-
tive value of 91%, 71%, 55%, and 95%, respectively. Seven
patients had bilateral occlusion at HyCoSy, two of them had
bilateral patency at LPS, and the other five cases confirmed
bilateral occlusion. In Table 2, we report the results of the
CnTI-SonoVue-HyCoSy compared with HSG/LPS. CnTI-
SonoVue-HyCoSy had a sensitivity, specificity, and positive
and negative predictive value of 87%, 84%, 69%, and 94%,
respectively. Four patients had bilateral occlusion at CnTI-
SonoVue; only one was not confirmed and showed a bilateral
patency at LPS.The diagnostic accuracy of air/saline-HyCoSy
and CnTI-SonoVue-HyCoSy compared with HSG/LPS were
77% and 85%, with a Cohen’s kappa of 0.52 and 0.66,
respectively.




Patent 49 3 52
Occluded 9 20 29
Total 58 23 81
Finally, we evaluated the kappa value and the diagnostic
accuracy for air/saline-HyCoSy and CnTI-SonoVue-HyCoSy
calculated in the first half (𝑛 = 41) and in the second
half (𝑛 = 40) of examinations. The diagnostic accuracy of
air/saline-HyCoSy in the two subsequent series improved
from 70% to 80%, while that for CnTI-SonoVue-HyCoSy did
not increase and was 85% in both series. The kappa value
of air/saline-HyCoSy improved from 0.42 to 0.57, while for
CnTI-SonoVue-HyCoSy it did not significantly change and
was 0.68 in the first half and 0.64 in the second half of
examinations. No pelvic infection occurred in any patient
after the two-step HyCoSy and HSG or LPS.
3.2. Study Two. We enrolled two hundred infertile patients
who underwent IUI and met all inclusion criteria described
before. In this group mean women age was 36 ± 4.9 years
and mean BMI was 23 ± 3.0 (range 16.8–30) Kg/m2. Mild
asthenoteratozoospermia and male infection for HIV or
HCV infection were infertility causes for the majority of
couples (𝑛 = 140) and unexplained infertility was the second
cause (𝑛 = 60). Performing air/saline-HyCoSy we found
that 154 patients (77%) showed bilateral patency; in 18 cases
(9%), no contrast mediumwas seen, and we considered them
bilateral tubal occlusion; in 28 cases (14%), only monolateral
passage was seen. 336 (84%) tubes were patent, 61 (15,3%)
were occluded, and 3 (0,7%) were absent for previous surgery.
154 couples underwent superovulation and IUI. The mean
number of treatments per couplewas 4.13. 70%of pregnancies
were conceived in the first three cycles. Six (3%) pregnancies
were multiple. The pregnancy rate for couple up to 6 cycles
was 78% and for IUI cycles was 20%. No cases of ectopic
pregnancy were registered.
4. Discussion
During the evaluation of an infertility couple one of the
crucial point is to understand if the tubes are patent or not in
order to decide which type of procedure we have to perform.
Laparoscopy is considered the gold standard but, obviously,
this cannot be considered as a screening test. We tried to
determine which test for tubal patency is more tolerable for
patients, less expensive, andwith a good sensibility.This study
analyses the possible advantages of different techniques that
combine second-generation contrast media with a dedicated
sonographic technology and in the second study air/saline-
HyCoSy as an efficient test to screen patients that desire
a child through a Reproductive Program is analysed. Our
results show that the kappa value of CnTI-SonoVue HyCoSy
reaches an efficient agreement (kappa 0.66) with the final
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diagnosis, whereas the traditional air/saline-Hy-CoSy yielded
a kappa value of 0.52, corresponding to moderate agreement
with the reference standard. This latter value obtained by
air/saline-HyCoSy confirms most of the literature reporting
these techniques [11–16]. The very high normal predictive
value (95%) of air/saline-HyCoSy may suggest that this
procedure can be performed as a screening examination
to avoid the use of more expensive contrast media. In our
results, inconclusive examinations were grouped together
with the “occluded” group. The positive predictive value,
excluding these inconclusive cases, improved from 55% to
72% for air/saline-HyCoSy and from 69% to 80% for CnTI-
SonoVue-HyCoSy, with a Cohen’s kappa of 0.70 and 0.76,
respectively. Considering the two techniques comparable for
efficiency, in the second part of our study we performed only
air/saline-HyCoSy. Our results show that pregnancy rate in a
group of subfertile patients with established patent tubes is
comparable to the pregnancy rate in the fertile population
similar for female age. These results, although indirectly,
suggest that air/saline-HyCoSy has a good specificity and we
can consider air/saline-HyCoSy an ideal one-step procedure
to assess tubal patency, also considering the minor cost, due
to the use of saline only and no need of dedicated 3D software.
In study one, we perform the two sequential techniques
during the same examination with the same catheter, avoid-
ing any additional discomfort to the patient. These second-
generation contrast media that are used with the tuned
imaging technology can be proposed in cases of positive
diagnoses of tubal occlusion or in inconclusive results. By
means of CnTI-SonoVue-HyCoSy, we obtained a sensitivity
and specificity of 87% and 84%, respectively. Our results are
in agreement with other investigators who reported their
findings on smaller series [16, 17], showing that positive
contrast agents are more efficient than saline solution. In
addition to this, our results show that the use of second-
generation contrast media does not require a learning period
as observed in our series for air/saline-HyCoSy [17]. We can
explain this by the long persistence of a positive contrast
agent versus the short imaging effect of saline boosted by
air injection, since bidimensional ultrasound requires the
evaluation of different sections to spot the whole course of
fallopian tubes. Contrast agents persistently “paint” the tubes
and make it easier and more reliable for the sonographer to
come to a final diagnosis.
However, it is important to distinguish the clinical mean-
ing of “tubal factor” and “tubal patency” since patency does
not imply a normal function of the fallopian tubes. Tubal
peristalsis and integrity of the ciliate epithelium are manda-
tory to permit the oocyte fertilization and a normal intrauter-
ine implantation of the embryo. This fine synchronization
represents one of the key factors for successful pregnancy,
and its absence would explain a part of idiopathic infertility.
From this perspective, macroscopic imaging of tubal factor,
whatever its accuracy in confirming tubal patency, does not
represent a final assessment of the tubal factor. LPS provides
an accurate assessment of the pelvis and the characteristics of
the tubes and its ligaments, but tubal patency is eventually
proved by chromopertubation obtained after major stress
applied to the uterine cavity by a hysteron manipulator.
Tubal spasm and selected sided spill, which imbalances tubal
resistance, can occur at the LPS assessment of tubal patency
as well as during more gentle procedures such as HSG and
HyCoSy.
5. Conclusions
CnTI-SonoVue-HyCoSy is more accurate than air/saline-
HyCoSy for the assessment of fallopian tubes. The very high
normal predictive value of air/saline-HyCoSy suggests that
this procedure could be performed as a screening exami-
nation, whereas CnTI-SonoVue-HyCoSy could be used as a
second-step technique. In a subfertile population, air/saline-
HyCoSy proves to be an efficient screeningmethod to attempt
tubal patency to select patients who can undergo intrauterine
insemination as first step of a medical assisted procreation
program.
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